Trump’s Trade Gamble Will Continue, Despite Supreme Court Rebuke
The president seems as intent on tariffs as ever and argues that his trade agenda is succeeding, despite little evidence to support it
Inside the Big Tech Lobbying Machine Aiming to Halt Social Media Bans
Tech giants, including Meta and Alphabet, are spending lavishly on splashy billboard ads, courting on-the-fence politicians and bulking up their ranks of lobbyists.
Six Questions on the Future of Trump’s Tariffs
The Supreme Court’s ruling on the president’s tariffs has jolted Washington and the business world. Here’s what to watch next.
He Researched Dishonesty. He Got Friendly With Jeffrey Epstein.
Dan Ariely, a behavioral scientist at Duke, sought out the convicted sex offender for his research. Their yearslong correspondence suggests it wasn’t all business.
For India, Buying Russian Oil Just Got More Complicated
India’s prime minister acceded to many of President Trump’s demands under pressure of heavy tariffs. It would be awkward to reject them now.
Fred Segal Has a New Owner. This Time It’s Aritzia.
The storied Los Angeles retailer, once recognized as an arbiter of West Coast style, has been acquired by the mass-market brand Aritzia.
Trump Doubles Down on Closing Tax Loophole on Cheap Imports
The exemption was shut down last year by President Trump based, in part, on the same legal grounds as the tariffs that were invalidated by the Supreme Court.
‘Murky Waters’ for Global Businesses After Trump’s Tariff Loss
Even after the Supreme Court invalidated many of the president’s levies, foreign leaders and executives assume that U.S. tariffs are here to stay, in one form or another.
After Supreme Court Loss, Trump Plans to Impose Global Tariffs Using Different Laws
The administration has been preparing for months for the possibility that the Supreme Court would rule against the president and developed contingency plans.
With Tariff Changes, Consumers May Be Stuck in a Waiting Game
Some companies could decide to temper price increases, but the effect would take time to materialize.
Businesses Celebrate Tariff Relief, And Brace for New Uncertainty
The Supreme Court’s ruling against many of President Trump’s tariffs cheered executives who set to work seeking refunds on their duties.
After Tariff Decision, What Happens to Trump’s Deals With China, Canada and Europe?
The Supreme Court’s decision to invalidate many of President Trump’s tariffs raised questions about what would become of agreements struck with major U.S. trading partners.
Ask The Morning: The Supreme Court’s Tariff Ruling
The justices struck down a central piece of President Trump’s agenda. What does that mean?
Supreme Court Tariff Ruling to Spur Chaotic Refund Process
The Trump administration says it could take years and additional litigation for importers to get their money back.
Tariff Whiplash Clouds Outlook for Federal Budget
The tariffs thrown out by the Supreme Court had become an important revenue source. President Trump said he could replace that money with other levies.
Christopher S. Wren, Times Bureau Chief in Hostile Lands, Dies at 89
Over three decades, he reported from Moscow, Beijing, Tehran and elsewhere and wrote well-received books based on his reporting, including one about his globe-trotting cat.
Supreme Court Justices Strike Down Trump’s Tariffs
President Trump was the first to invoke the International Emergency Economic Powers Act of 1977 to set tariffs on imported goods from more than 100 countries.
Here’s the latest.
President Trump is the first to invoke the International Emergency Economic Powers Act of 1977 to set tariffs on imported goods from more than 100 countries.
Why the United States Is Seeing an Ongoing Tourism Slump
Last year, the U.S. was the only major destination to see a decline in international travelers. With increased scrutiny at the border, ICE violence and unpredictable policies, the new year isn’t looking better.
A Cancer Detection Test Fails in Major Study
A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in later stages of the disease.